Regeneron Pharmaceuticals
REGN
#254
Rank
โ‚น6.478 T
Marketcap
โ‚น58,955
Share price
-1.68%
Change (1 day)
-24.78%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): โ‚น3,085

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น3,232. In 2022 the company made an earnings per share (EPS) of โ‚น3,505 a decrease over its 2021 EPS that were of โ‚น6,613.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น3,085-11.99%
2022โ‚น3,505-47%
2021โ‚น6,613133.36%
2020โ‚น2,83469.13%
2019โ‚น1,675-14.44%
2018โ‚น1,958100.71%
2017โ‚น975.6931.78%
2016โ‚น740.4138.96%
2015โ‚น532.8272.55%
2014โ‚น308.79-17.55%
2013โ‚น374.53-44.98%
2012โ‚น680.73-422.54%
2011-โ‚น211.0592.13%
2010-โ‚น109.8549.41%
2009-โ‚น73.52-15.84%
2008-โ‚น87.36-36.88%
2007-โ‚น138.40-9.6%
2006-โ‚น153.104.12%
2005-โ‚น147.04-323.68%
2004โ‚น65.74-135.51%
2003-โ‚น185.10-24.38%
2002-โ‚น244.7956.35%
2001-โ‚น156.56187.3%
2000-โ‚น54.49-16%
1999-โ‚น64.87177.78%
1998-โ‚น23.35-35.71%
1997-โ‚น36.33-68.42%
1996-โ‚น115.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,224-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น355.50-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,597-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,218-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น323.50-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น275.08-91.49%๐Ÿ‡ซ๐Ÿ‡ท France